OC
FURX

Oppenheimer & Co’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

Oppenheimer & Co’s Portfolio FURX Stock Details FURX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-9,475
Closed -$417K – 1508
2013
Q3 		$417K Hold
9,475
– – 0.01% 829
2013
Q2 		$323K Buy
+9,475
New +$333K 0.01% 899

Other funds holding FURX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Oppenheimer & Co's FURX Position: Q4 2013 in Review

Oppenheimer & Co sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q4 2013, closing a stake of 9,475 shares — an estimated $417K sold.

Oppenheimer & Co first reported a position in FURX in Q2 2013 and held it in 2 quarters. The position peaked at $417K in Q3 2013. 84 funds tracked by Wall St. Rank hold FURX as of Q4 2013.

  • Oppenheimer & Co reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q4 2013 after selling out during the quarter.
  • Oppenheimer & Co sold 9,475 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q4 2013, an estimated $417K.
  • Oppenheimer & Co first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 2 quarters.
  • Oppenheimer & Co's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $417K in Q3 2013.
  • 84 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q4 2013.

Based on Oppenheimer & Co's 13F filing for Q4 2013, filed 12 Feb 2014.